Hybrid Conferencee

International Conference on Viral Infection and Immune Response (ICVIIR - 26)

30th - 31st December 2026 | Larnaca, Cyprus
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Larnaca. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Larnaca event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Larnaca conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Larnaca, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Larnaca."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Viral Infectious Diseases: Pathogenesis and Treatment

This track focuses on the mechanisms of viral pathogenesis and the latest advancements in treatment strategies for various viral infectious diseases. Discussions will include antiviral therapies, vaccine development, and emerging treatment modalities.

Track 02

Molecular Epidemiology of Viral Infections

This session will explore the molecular epidemiology of viral infections, emphasizing the genetic and environmental factors influencing viral spread and evolution. Researchers will present findings on viral transmission dynamics and population genetics.

Track 03

Zoonotic Viral Diseases: Challenges and Solutions

This track addresses the public health implications of zoonotic viral diseases, highlighting the transmission pathways from animals to humans. Participants will discuss prevention strategies, surveillance, and control measures.

Track 04

Immunological Responses to Viral Infections

This session will examine the human immune response to viral infections, including innate and adaptive immunity. Topics will cover immune evasion strategies employed by viruses and the implications for vaccine design.

Track 05

Public Health Strategies in Infectious Disease Control

This track will focus on public health practices aimed at controlling viral infections, including outbreak response, vaccination campaigns, and health education. Case studies will illustrate successful interventions and challenges faced in various settings.

Track 06

Emerging Viral Threats: Surveillance and Response

This session will highlight the importance of surveillance systems in detecting and responding to emerging viral threats. Discussions will include global collaboration, data sharing, and the role of technology in outbreak prediction.

Track 07

Vaccinology: Innovations and Challenges

This track will delve into the latest innovations in vaccine development for viral diseases, addressing both traditional and novel approaches. Challenges in vaccine distribution, public acceptance, and efficacy will also be discussed.

Track 08

Ethical Considerations in Viral Research and Public Health

This session will explore the ethical implications of research and public health interventions related to viral infections. Topics will include informed consent, equity in vaccine distribution, and the balance between individual rights and community health.

Track 09

Viral Hemorrhagic Fevers: Clinical and Epidemiological Insights

This track will focus on viral hemorrhagic fevers, examining clinical presentations, epidemiological trends, and management strategies. Experts will discuss the challenges of diagnosing and treating these severe infections.

Track 10

Viral Hepatitis: Advances in Research and Treatment

This session will cover the latest research on viral hepatitis, including epidemiology, pathogenesis, and treatment options. Discussions will highlight advancements in antiviral therapies and the impact of hepatitis on public health.

Track 11

Respiratory Viruses: Impact on Global Health

This track will address the impact of respiratory viruses on global health, focusing on influenza, coronaviruses, and other respiratory pathogens. Participants will discuss prevention strategies, vaccine development, and the implications for public health policy.